Read + Share
Amedeo Smart
Independent Medical Education
O'Rourke K. Pembrolizumab is effective for endometrial cancer. Cancer 2022;128:1886-1887.PMID: 35467764
Email
LinkedIn
Facebook
Twitter
Privacy Policy
